Table 4.   .

Reported Adherence to Prescribed Occlusion Therapy at 2, 3, and 6 Months after Surgery and Odds of Achieving Grating Visual Acuity within Normal Limits 12 Months after Surgery in IATS Participants

		Vision WNL	Poorer Vision	Crude		Adjusted*
				OR	95% CI	OR	95% CI
Overall	None	8 (38.1%)	13	0.36	(0.12,1.05)	0.45	(0.15,1.38)
	Some	25 (54.3%)	21	0.69	(0.29,1.62)	0.83	(0.33,2.06)
	All	26 (63.4%)	15	1.0	Ref	1.0	Ref
IOL	None	4 (28.5%)	10	0.22	(0.05,0.95)	0.23	(0.05,1.03)
	Some	10 (47.6%)	11	0.49	(0.14,1.72)	0.65	(0.18,2.37)
	All	13 (65.0%)	7	1.0	Ref	1.0	Ref
CL	None	4 (57.1%)	3	0.82	(0.14,4.66)	1.91	(0.26,14.02)
	Some	15 (60.0%)	10	0.92	(0.28,3.03)	1.37	(0.36,5.21)
	All	13 (61.9%)	8	1.0	Ref	1.0	Ref

^* Adjusted for type of surgery, age at surgery, and having had a complication or additional surgery for overall. For treatment-specific analyses, adjusted for age at surgery and having had a complication or additional surgery.